Hemochromatosis gene (HFE) mutations in South East Asia: A potential for iron overload

Blood Cells, Molecules, and Diseases

Volumn 30, Issue 3, 2003, Pages 302-306

  Pointon, Jennifer J ^a   Viprakasit, Vip ^a,b   Miles, Katie L ^a   Livesey, Karen J ^a   Steiner, Michael ^c   O'Riordan, Sean ^d   Hien, Tran T ^d   Merryweather Clarke, Alison T ^a   Robson, Kathryn J H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d Centre for Tropical Diseases Vietnam   (Viet Nam)

Author keywords

Allele frequency; Hemochromatosis; Vietnamese mutation

Indexed keywords

ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK FACTOR; SOUTHEAST ASIA; THAILAND; VIET NAM;

EID: 0037961858     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00041-X     Document Type: Article

References (42)

1. Bothwell T.H., Charlton R.W., Motulsky A.G. Hemochromatosis. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Basis of Inherited Disease. 1995;2237-2269 McGraw Hill, New York.
2. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:1996;399-408.
3. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am. J. Hum. Genet. 61:1997;762-764.
4. Risch N. Haemochromatosis, HFE and genetic complexity. Nat. Genet. 17:1997;375-376.
5. Fairbanks V.F., Brandhagen D.J., Thibodeau S., Snow K., Wollan P.C. H63D is an haemochromatosis associated allele. Gut. 43:1998;441.
6. Merryweather-Clarke A.T., Pointon J.J., Jouanolle A.M., Rochette J., Robson K.J.H. Geography of HFE C282Y and H63D mutations. Genet. Test. 4:2000;183-198.
7. Chang J.-G., Liu T.-C., Lin S.-F. Rapid diagnosis of the HLA-H gene Cys 282 Tyr mutation in hemochromatosis by polymerase reaction - a very rare mutation in the Chinese population. Blood. 89:1997;3492-3493.
8. Cullen L.M., Gaom X., Easteal S., Jazwinska E.C. The hemochromatosis 845 G→A and 187 C→G mutations prevalence in non-Caucasian populations . Am. J. Hum. Genet. 62:1998;1403-1407.
9. Choi S.J., Min W.-K., Chun S., et al. Frequencies of C282Y and H63D mutations and transferrin indices in the Korean population. Clin. Chem. Lab. Med. 40:2002;689-692.
10. Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., Robson K.J.H. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 3:1997;275-278.
11. Rochette J., Pointon J.J., Fisher C.A., et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am. J. Hum. Genet. 64:1999;1056-1062.
12. Roth M.-P., Giraldo P., Hariti G., et al. Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethopia, and Senegal. Immunogenetics. 46:1997;222-225.
13. Agostinho M.F., Arruda V.R., Basseres D.S., et al. Mutation analysis of the HFE gene in Brazilian populations. Blood Cells Mol. Dis. 25:1999;324-327. doi:bcmd.1999.0260.
14. de Villiers J.N.P., Hillermann R., Loubser L., Kotze M.J. Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria. Hum. Mol. Genet. 8:1999;1522-1571.
15. Tsui W.M.S., Lam P.W.Y., Lee K.C., et al. The C282Y mutation of the HFE gene is not found in Chinese haemochromatotic patients multicentre retrospective study . Hong Kong Med. J. 6:2000;153-158.
16. Pointon J.J., Wallace D., Merryweather-Clarke A.T., Robson K.J.H. Uncommon mutations in the hemochromatosis gene. Genet. Test. 4:2000;151-161.
17. Piperno A., Arosio C., Fossati L., et al. Two novel mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology. 119:2000;441-445. doi:10.1053/gast.2002.9369.
18. Phillips M., Meadows C.A., Huang M.Y., Millsin A., Lyon E. Simultaneous detection of C282Y and H63D hemochromatosis mutations by dual-color probes. Mol. Diagn. 5:2000;107-116.
19. Rosmorduc O., Poupon R., Nion I., et al. Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology. 119:2000;1075-1086.
20. R. Mariani, A. Salvioni, V. Mauri, et al., Prevalence of E168X and W169X HFE mutations in healthy blood donors in northern Italy. Bioiron 2001 World Congress on Iron Metabolism, August 18-23, 2001, Cairns, Australia, p. 129.
21. Steiner M., Ocran K., Genschel J., et al. A homozygous HFE gene splice mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese origin. Gastroenterology. 122:2002;789-795. doi: 10.1053/gast.2002.31884.
22. Beutler E., Griffin M.J., Gelbart T., West C. A previously undescribed nonsense mutation of the HFE gene. Clin. Genet. 61:2002;40-42.
23. Henz S., Reichen J., Liechti-Gallati S. HLA-H gene mutations and haemochromatosis the likely association of H63D with mild phenotype and the detection of S65C, a novel variant in exon 2 . J. Hepatol. 26:(Suppl. 1):1997;57.
24. Old J.M. Fetal DNA analysis. Davies K.E. Human Genetic Disease Analysis - A Practical Approach. 2nd ed. 1993;2-4 IRL Press, Oxford.
25. Worwood M., Shearman J.D., Wallace D.F., et al. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut. 41:1997;841-844.
26. Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., et al. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nat. Genet. 23:1999;271.
27. Vu-Trieu A., Djoulah S., Tran-Thi C. HLA-DR and -DQB1 DNA polymorphisms in a Vietnamese Kinh population from Hanoi. Eur. J. Immunogenet. 24:1997;345-356.
28. Ivonova R., Astrinidis A., Lepage V., et al. Mitochrondrial DNA polymorphism in Vietnamese population. Eur. J. Immunogenet. 26:1999;417-422.
29. Kng C., Ng F.-H., Ng W.-F., et al. A Chinese patient with non-HFE-linked iron overload. J. Clin. Gastroenterol. 33:2001;69-71.
30. Oliver M., Scully L., Guiraudon C., Adams P.C. Non-HLA-linked hemochromatosis in a Chinese woman. Dig. Dis. Sci. 40:1995;1589-1591.
31. Jackson H.A., Carter K., Darke C., et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br. J. Haematol. 114:2001;474-484.
32. Beutler E., West C. New diallelic markers in the HLA region of chromosome 6. Blood Cells Mol. Dis. 23:1997;219-229. doi:MD970139.
33. Aguilar-Martinez P., Thelicide C., Jeanjean P., Masmejean C., Giansily M., Schved J.-F. Haplotype analysis of the HFE gene implication for the origins of hemochromatosis related mutations . Blood Cells Mol. Dis. 25:1999;166-169. doi:bcmd.1999.0242.
34. D.J. Weatherall, J.B. Clegg, in: The Thalassaemia Syndromes, Blackwell Sci., Oxford, UK, 2001, pp. 244-245.
35. D.J. Weatherall, J.B. Clegg, in: The Thalassaemia Syndromes, Blackwell Sci., Oxford, UK, 2001, pp. 268-269.
36. Rees D.C., Luo L.Y., Thein S.L. Nontransfusional iron overload in thalassemia association with hereditary hemochromatosis . Blood. 90:1997;3234-3236.
37. Cappellini M.D., Fargion S.R., Sampietro M., Graziadei G., Fiorelli G. Nontransfusional iron overload in thalassemia intermedia role of the hemochromatosis allele . Blood. 92:1998;4479-4480.
38. Melis M.A., Cau M., Deidda F., Barella S., Cao A., Galanello R. H63D mutation in the HFE gene increases iron overload in β-thalassemia carriers. Haematologica. 87:2002;242-245.
39. Aguilar-Martinez P., Schved J.F., Baden C., et al. Iron overload in thalassaemias and genetic haemochromatosis. Eur. J. Haematol. 64:2000;279-280.
40. Longo F., Zecchini G., Sbaiz L., Fischer R., Piga A., Camaschella C. The influence of hemochromatosis mutations on iron overload of thalassemia major. Haematologica. 84:1999;799-803.
41. Ruiz-Arguelles G.J., Garces-Eiseles J., Reyes-Nunez V. Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor observations in a thalassemic kindred . Rev. Invest. Clin. 53:2001;117-120.
42. Borgna-Pignatti C., Solinas A., Bombieri C., et al. The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated. Br. J. Haematol. 103:1998;813-816.